Artis BioSolutions
Artis BioSolutions is a growth equity company that provides capital and operational expertise to accelerate discovery, development, and commercial production of genetic medicines and biologics. The firm supports programs from Phase 1 to commercial readiness and focuses on scaling manufacturing, technology transfer, and analytical development for modalities including cell & gene, mRNA, peptide, and oligonucleotide therapies.
Services
Growth equity capital
Provides capital support and growth-equity investments to small and mid-size, founder-led companies to enable scaling and commercialization.
Operational scaling and manufacturing support
Operational execution and hands-on support to scale clinical manufacturing to commercial GMP production, leveraging experience deploying capital and facilities.
Technology transfer and commercialization support
Expertise in technology transfer to enable corporate partners and contract manufacturing organizations to commercialize novel products.
Access to technical capabilities and R&D support
Access to expertise and capabilities in nucleic acids, enzymes, peptides, lipid nanoparticles (LNP), reagents, and analytical development to support drug product and delivery formulation development.
Network and strategic guidance
Access to a network of industry experts, commercial guidance, and business development support to accelerate growth and partnerships.
Growth equity capital
Provides capital support and growth-equity investments to small and mid-size, founder-led companies to enable scaling and commercialization.
Operational scaling and manufacturing support
Operational execution and hands-on support to scale clinical manufacturing to commercial GMP production, leveraging experience deploying capital and facilities.
Technology transfer and commercialization support
Expertise in technology transfer to enable corporate partners and contract manufacturing organizations to commercialize novel products.
Access to technical capabilities and R&D support
Access to expertise and capabilities in nucleic acids, enzymes, peptides, lipid nanoparticles (LNP), reagents, and analytical development to support drug product and delivery formulation development.
Network and strategic guidance
Access to a network of industry experts, commercial guidance, and business development support to accelerate growth and partnerships.
Portfolio
Acquired by Artis BioSolutions as part of Artis' market entry to expand manufacturing and commercialization capabilities for advanced therapies.
#Cell and gene therapy manufacturing (CDMO)
Acquired by Artis BioSolutions as part of Artis' market entry to expand manufacturing and commercialization capabilities for advanced therapies.
#Cell and gene therapy manufacturing (CDMO)